NKE
33
2
SCHW
65
-2
NTAP
61
-3
TRV
56
-2
TXT
62
2
CI
52
-7
MU
32
-6
URBN
66
2
RRC
60
-3
RIG
44
-2
EMC
53
-3
EFX
41
-2
DG
12
2
DOV
73
4
DE
36
-2
PG
50
2
AVY
53
2
GOOGL
59
-8
DTE
38
-4
PFG
50
-2
NKE
33
2
SCHW
65
-2
NTAP
61
-3
TRV
56
-2
TXT
62
2
CI
52
-7
MU
32
-6
URBN
66
2
RRC
60
-3
RIG
44
-2
EMC
53
-3
EFX
41
-2
DG
12
2
DOV
73
4
DE
36
-2
PG
50
2
AVY
53
2
GOOGL
59
-8
DTE
38
-4
PFG
50
-2
Financhill
Back

BridgeBio Pharma Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
57

BBIO
BridgeBio Pharma

Last Price:
24.10
Seasonality Move:
13.43%
Sell
32

ALNY
Alnylam Pharmaceuticals

Last Price:
258.10
Seasonality Move:
10.85%
Buy
57
BridgeBio Pharma (BBIO) is a Buy

Is BridgeBio Pharma a Buy, Sell or Hold?

  • The current BridgeBio Pharma [BBIO] share price is $24.79. The Score for BBIO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • BBIO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $264.47. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BBIO Stock Price Chart

What is BridgeBio Pharma's stock price today?

  • The BridgeBio Pharma share price today is $24.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $264.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

BBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 47.06 Sell
Chaikin Money Flow: -1475647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.15 - 25.99) Sell
Bollinger Bands (100): (24.16 - 27.4) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.22 Sell
Relative Strength Index (14 RSI): 40.3 Sell
Chaikin Money Flow: -604310 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (270.63 - 291.59) Sell
Bollinger Bands (100): (248.48 - 281.74) Sell

BBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.6 Sell
20-day SMA: 25.07 Sell
50-day SMA: 25.87 Sell
200-day SMA: 27.68 Sell
8-day EMA: 25.33 Sell
20-day EMA: 25.23 Sell
50-day EMA: 25.48 Sell
200-day EMA: 26.72 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 271.39 Sell
20-day SMA: 281.16 Sell
50-day SMA: 274.16 Sell
200-day SMA: 209.19 Buy
8-day EMA: 272.22 Sell
20-day EMA: 275.95 Sell
50-day EMA: 272.52 Sell
200-day EMA: 230.17 Buy

BridgeBio Pharma Earnings Growth & BBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.77 per share, and a decrease next year of $0.66 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

BridgeBio Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):